Search the Newsreel

Renasant Corp. (RNST) Q2 2026 Earnings Report - Results, Call & Slides

Skeena Resources (NYSE:SKE) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS

Genasys Inc earnings missed by $0.12, revenue fell short of estimates

Genasys Inc (NASDAQ: GNSS) reported third-quarter earnings per share (EPS) of $-0.100, missing analyst estimates by $0.12, and revenue of $7.3M, significantly below the consensus of $19.2M. The company's stock has seen a -4.470% decline in the last three months but is up 4.270% …

Earnings call transcript: Genasys misses Q3 2026 estimates as stock slips after hours

Enact Holdings Inc stock hits all-time high at 49.9 USD

Enact Holdings Inc. (ACT) stock reached an all-time high of $49.90, currently trading at $49.83 with a market capitalization of $6.85 billion. This milestone follows a 32.2% increase over the past year and a 25.9% year-to-date gain, reflecting strong investor confidence despite being considered …

Skeena Gold & Silver Q2 Results: Eskay Creek targets 2027 production

Skeena Resources Limited released its Q2 2026 interim results, focusing on the construction progress of its Eskay Creek Gold-Silver Project in British Columbia. The company is targeting initial production and cash flow from the project in Q2 2027. No specific financial figures for the …

FASTENAL CO SEC Filing (Aug 13, 2026)

This article details a Form 144 SEC filing by Fastenal Co. on August 13, 2026. The filing indicates a proposed sale of 9,258 shares of common stock through a stock option exercise, with an aggregate market value of $475,758.19. The transaction was handled by …

Skeena progresses Eskay Creek toward initial production in Q2 2027

Skeena Gold & Silver (TSX: SKE, NYSE: SKE) announced its interim financial results for Q2 2026, confirming that its fully permitted Eskay Creek Gold-Silver Project in British Columbia is under construction. The company targets initial production and cash flow from the project in the …

Skeena Gold & Silver Reports Q2 2026 Financial Results

Skeena Resources Limited VANCOUVER, British Columbia, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Skeena Resources Limited (TSX: SKE, NYSE: SKE) ("Skeena Gold & Silver", "Skeena" or the "Company") reports interim financial results for the quarter ended June 30, 2026. The interim financial statements and management's …

Skeena Resources (NYSE: SKE) posts H1 2026 loss and secures US$750M notes

Cadrenal Therapeutics reports Q2 2026 net loss of $3.3M; cash runway into Q1 2027

Cadrenal Therapeutics reported a net loss of $3.3 million for Q2 2026, an improvement from $3.7 million in Q2 2025. The company's cash and equivalents of approximately $4.2 million are expected to fund operations into Q1 2027. Additionally, Cadrenal launched a strategic partnering process …

Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

Cadrenal Therapeutics (NASDAQ: CVKD) reported a Q2 2026 net loss of $3.3 million, narrowing from $3.7 million in Q2 2025, and operating expenses decreased to $3.3 million. The company announced positive Phase 2 data for CAD-1005, showing over a 25% absolute reduction in thrombotic …

Genasys: Fiscal Q3 Earnings Snapshot

This article provides a brief earnings snapshot for Genasys' fiscal Q3. Without further details, it indicates a focus on financial reporting for the quarter.

Genasys Inc. (NASDAQ: GNSS) boosts margins as Q3 revenue slips to $7.3M

Genasys Inc. reported a Q3 2026 revenue of $7.3 million, a decrease from the previous year, but saw significant improvements in profitability with gross margin rising to 57.1%. The company narrowed its GAAP net loss and improved adjusted EBITDA, attributing these gains to a …

Fastenal Co. stock underperforms Thursday when compared to competitors

Fastenal Co. (FAST) stock decreased by 1.69% on Thursday, closing at $51.34, even as the broader market saw gains with the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) rising. This marks the second consecutive day of losses for the company's stock.

Genasys Inc. (GNSS) boosts revenue yet turns to stockholders’ deficit and adds high-cost debt

Genasys enters fiscal Q4 with backlog above $69M, expects record year

Genasys Inc. reported its fiscal Q3 2026 financial results, with revenue of $7.3 million and a GAAP net loss of $4.7 million. Despite supply chain issues and payment delays affecting the quarter, the company secured significant new orders and extended its term loan maturity. …

Zenas BioPharma (NASDAQ:ZBIO) Issues Earnings Results

Ciena Corp Stock (CIEN) Moved Up by 5.80% on Aug 13: A Full Analysis

Ciena Corp (CIEN) stock rose by 5.80% on August 13, driven by favorable industry trends, international contract wins, and technological advancements in optical networking. The company secured a significant network build contract with e& UAE and successfully completed a quantum-safe networking trial, demonstrating its …

TENX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Tenax Therapeutics

SueWallSt is investigating potential securities claims against Tenax Therapeutics (TENX) after its shares dropped 84-85% following the failure of its Phase 3 LEVEL trial of TNX-103 to meet primary and key secondary endpoints. Investors who suffered losses due to this decline are encouraged to …

CVLG | Covenant Logistics Group, Inc. Financials - Revenue Breakdown

REG - Chenavari Toro IncFd - Scrip Dividend Election Price

Ciena (CIEN) Stock Looks Undervalued Following Its Near 10x Three Year Run

Ciena (CIEN) has seen a significant stock increase over the past three years, yet its valuation presents a mixed picture. A Discounted Cash Flow (DCF) model suggests the stock is undervalued by 33.6% due to strong projected cash flows, especially with AI-driven demand. However, …

Fastenal (FAST) Up 15.1% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Fastenal (FAST). Shares have added about 15.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Fastenal due for …

Zenas BioPharma (NASDAQ:ZBIO) Stock Price Down 6.6% on Disappointing Earnings

Zenas BioPharma (NASDAQ:ZBIO) experienced a 6.6% stock price drop after reporting disappointing quarterly earnings, with an EPS of $(1.77) against an estimated $(1.12) and revenue of $1 million against a $15 million forecast. Despite the earnings miss, analysts generally maintain a "Moderate Buy" rating …

Ciena Stock Jumps 11% After Landing Major Middle East Network Deal and Completing Quantum Trial

Ciena (CIEN) stock rose 11% after securing a major DWDM network deal with e& UAE and successfully completing a quantum-safe networking trial with Quantum Corridor and Toshiba. These developments highlight Ciena's continued success in securing large service provider contracts and its forward-thinking approach to …

Ciena Stock Outlook: Is Wall Street Bullish or Bearish?

Businessman work with ai for economy analysis financial result by digital augmented reality graph by Natee K Jindakum via Shutterstock Ciena Corporation (CIEN), headquartered in Hanover, Maryland, is a network technology company that provides hardware, software, and services for various network operators. Valued at …

Renasant Corporation Declares Quarterly Dividend

Renasant Corporation TUPELO, Miss., Aug. 13, 2026 (GLOBE NEWSWIRE) -- The board of directors of Renasant Corporation (NYSE: RNST) approved the payment of a quarterly cash dividend of twenty-four cents ($0.24) per share to be paid September 30, 2026, to shareholders of record as …

Zenas BioPharma, Inc. 2026: Revenue $1M, Net income ($111.46M), EPS ($1.77) — 10-Q Summary

Zenas BioPharma, Inc. (ZBIO) reported its financial results for the quarter ended 2026, showing revenue of $1M and a net loss of ($111.46M), with a diluted loss per share of ($1.77). These figures represent a significant decrease in revenue and an increase in net …

Form 8K Zenas Biopharma Inc For: 13 August By Investing.com

This article is a brief financial announcement from Investing.com, stating that Zenas Biopharma Inc. filed a Form 8K on August 13th. The filing is related to the company's financial activities and includes the stock symbol ZBIO, which showed a -6.68% change. The content primarily …

ZenaTech Drone Software Maps Grading and Drainage for AI Data Centers

ZenaTech has expanded its ZenaWorx drone-based construction monitoring software to include digital terrain modeling (DTM) capabilities, enabling precise measurement of cut-and-fill volumes, grading accuracy, and drainage for large-scale earthworks. The company announced its first paying customer for an AI data center construction project, targeting …

Equities Analysts Set Expectations for ENTA FY2026 Earnings

ZenaTech Buying Galena-Benchmark Engineering To Expand Its Drone Services Platform

ZenaTech has acquired Galena-Benchmark Engineering, a civil engineering and land surveying firm based in Idaho. This acquisition marks ZenaTech's 27th Drone as a Service acquisition and expands its presence to its 13th U.S. state, allowing it to integrate its drone technology into an established …

Earnings Flash (ZBIO) Zenas BioPharma Posts Q2 Loss $1.77 a Share, vs. FactSet Est of $1.12 Loss

Zenas BioPharma (ZBIO) announced a Q2 loss of $1.77 per share, which is significantly wider than FactSet's estimated loss of $1.12 per share. The company reported Q2 revenue of $1.0 million. Zenas BioPharma is a clinical-stage biopharmaceutical company focused on autoimmune diseases with lead …

Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Zenas BioPharma announced its second quarter 2026 financial results and provided a corporate update, highlighting the FDA's acceptance of the obexelimab BLA for IgG4-RD with a PDUFA date of May 27, 2027. The company also reported positive Phase 3 INDIGO trial results for obexelimab, …

Earnings Flash (ZBIO) Zenas BioPharma, Inc. Reports Q2 Revenue $1.0M